A Prospective Study on Relation of Subclinical Hypothyroidism During Pregnancy With its outcomes at SKMCH, Muzaffarpur, Bihar
Authors/Creators
- 1. Senior Resident, Department of Obstetrics and Gynaecology, Sri Krishna Medical College and Hospital, Muzaffarpur, Bihar
- 2. Professor and Head of Department, Department of Obstetrics and Gynaecology, Sri Krishna Medical College and Hospital, Muzaffarpur, Bihar
Description
Background: Both the mother and the foetus experience significant physiological stress throughout pregnancy. There is a significant risk of unfavourable outcomes for both the mother and the foetus when endocrine abnormalities like hypothyroidism are present during pregnancy. All pregnant women should be screened for subclinical hypothyroidism, especially in the Indian context where there is a higher risk of iodine deficit during pregnancy. Therefore, the purpose of this study was to determine how subclinical hypothyroidism affected the course of pregnancy. Method: A prospective analytical study was conducted at SKMCH, Muzaffarpur, Bihar from April 2022 to September 2022. The sample size was made up of 73 expectant women who visited the prenatal OPD. During the initial appointment, a thyroid profile (serum TSH, FT3 and FT4) was performed. TSH >2.5mIU/L in the first trimester, >3mIU/L in the second trimester, and >3.5mIU/L in the third trimester were the cutoff values used by the SCH to assess the findings. Information was recorded about the participants’ general characteristics. The participants checked in to assess the delivery method, the mother’s and fetus’s health, and any co-morbid conditions that might have developed. Women with SCH are treated as such. Results: Thyroid screening was done on 73 pregnant women, and 24.7% of them showed subclinical hypothyroidism. In contrast to 72.3% of euthyroid women, 55.6% of SCH women were under the age of 25. For iodized salt consumption, food type, and BMI, there was no discernible difference between the SCH and euthyroid groups (p>0.05). SCH was linked to increased incidences of elevated blood pressure (27.8% vs 7.3%, p=0.02) and low birth weight (38.9% vs 14.5%, p=0.03) in infants compared to euthyroid condition. In contrast to euthyroid women, the proportion of SCH women with anaemia and a low APGAR score was also higher. The significance was merely somewhat high. (Poor APGAR score: 27.8% vs. 9.1%; Anaemia: 72.2% vs. 45.5%, p=0.049). Conclusion: Indians have a rather high prevalence of subclinical hypothyroidism among pregnant women. Unfavourable maternal and foetal outcomes were observed in pregnant women with SCH, with a higher risk of high blood pressure and low birth weight neonates. In order to improve maternal and perinatal outcomes, routine maternal thyroid function testing is required.
Abstract (English)
Background: Both the mother and the foetus experience significant physiological stress throughout pregnancy. There is a significant risk of unfavourable outcomes for both the mother and the foetus when endocrine abnormalities like hypothyroidism are present during pregnancy. All pregnant women should be screened for subclinical hypothyroidism, especially in the Indian context where there is a higher risk of iodine deficit during pregnancy. Therefore, the purpose of this study was to determine how subclinical hypothyroidism affected the course of pregnancy. Method: A prospective analytical study was conducted at SKMCH, Muzaffarpur, Bihar from April 2022 to September 2022. The sample size was made up of 73 expectant women who visited the prenatal OPD. During the initial appointment, a thyroid profile (serum TSH, FT3 and FT4) was performed. TSH >2.5mIU/L in the first trimester, >3mIU/L in the second trimester, and >3.5mIU/L in the third trimester were the cutoff values used by the SCH to assess the findings. Information was recorded about the participants’ general characteristics. The participants checked in to assess the delivery method, the mother’s and fetus’s health, and any co-morbid conditions that might have developed. Women with SCH are treated as such. Results: Thyroid screening was done on 73 pregnant women, and 24.7% of them showed subclinical hypothyroidism. In contrast to 72.3% of euthyroid women, 55.6% of SCH women were under the age of 25. For iodized salt consumption, food type, and BMI, there was no discernible difference between the SCH and euthyroid groups (p>0.05). SCH was linked to increased incidences of elevated blood pressure (27.8% vs 7.3%, p=0.02) and low birth weight (38.9% vs 14.5%, p=0.03) in infants compared to euthyroid condition. In contrast to euthyroid women, the proportion of SCH women with anaemia and a low APGAR score was also higher. The significance was merely somewhat high. (Poor APGAR score: 27.8% vs. 9.1%; Anaemia: 72.2% vs. 45.5%, p=0.049). Conclusion: Indians have a rather high prevalence of subclinical hypothyroidism among pregnant women. Unfavourable maternal and foetal outcomes were observed in pregnant women with SCH, with a higher risk of high blood pressure and low birth weight neonates. In order to improve maternal and perinatal outcomes, routine maternal thyroid function testing is required.
Files
IJPCR,Vol14,Issue11,Article74.pdf
Files
(314.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4a99dbfa989c76447b912a2ba0817762
|
314.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-11-20
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue11,Article74.pdf
- Development Status
- Active
References
- 1. Rashid M, Rashid M H. Obstetric management of thyroid disease. Obstet Gynecol Surv. 2007; 62: 680–688. 2. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidismcomplicating pregnancy. Thyroid. 2002; 12: 63–6. 3. E Van den Boogaard, R Vissenberg, J A Land et al. Significance of subclinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Human Reproduction Update. 2011; 17: 605–619. 4. T Mannisto, P Mendola, J Grewal, Y Xie, Z Chen, S K Laughon. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. Journal of Clinical Endocrinology and Metabolism. 2013; 98(7): 2725–2733. 5. Pop V J, Kuijpens J L, van Baar A L, Verkerk G, Van Son M M, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. ClinEndocrinol (Oxf). 1999; 50: 149–155. 6. Haddow J E, Palomaki G E, Allan W C, Williams J R, Knight G J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341: 549–555. 7. Julvez J, Alvarez-Pedrerol M, Rebagliato M, Murcia M, Forns J, et al. Thyroxine levels during pregnancy in healthy women and early child neurodevelopment. Epidemiology. 2013; 24: 150–157. 8. P E Patton, M H Samuels, R Trinidad, and A B Caughey. Controversies in the management of hypothyroidism during pregnancy. Obstetrical and Gynecological Survey. 2014; 69(6): 346– 358. 9. Lazarus J H. Screening for thyroid dysfunction in pregnancy: is it worthwhile? J Thyroid Res. 2011; 3: 97- 112. 10. Garber J R, Cobin R H, Gharib H, Hennessey J V, Klein I, Mechanick J I, et al. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18(6): 988-1028. 11. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011; 21: e10811125. 12. Saki F, Dabbaghmanesh M H, Ghaemi SZ, Forouhari S, Omrani GR, Bakhshayeshkaram M. Thyroid function in pregnancy and its influences on maternal and fetal outcomes. Int J Endocrinol Metab. 2014; 12(4): e19378. 13. Sannaboraiah A, Upadhyaya R, Garag S, Krishnappa S. Subclinical hypothyroidism in pregnancy and outcomes. Int J Reprod Contracept Obstet Gynecol. 2017; 6(4): 1-7. 14. Dhanwal D K, Prasad S, Agarwal A K, Dixit V, Banerjee A K. High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India. Indian J EndocrinolMetab. 2013; 17(2): 281-4. 15. Abalovich M, Amino N, Barbour L A, Cobin R H, De Groot L J, Glinoer D. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007; 92(8): S1-47. 16. Gayathri R, Lavanya S, Raghavan K. Subclinical hypothyroidism and autoimmune thyroiditis in pregnancy- a study in South Indian subjects. J Assoc Physicians India. 2009; 57: 691-3. 17. Brian M Casey, Jodi S Dashe, C Edward Wells, Donald D McIntire, William Byrd, Kenneth J Leveno et al. Subclinical Hypothyroidism and Pregnancy Outcomes. The American College of Obstetricians and Gynecologists. 2005; 105(2): 239-45.18. Liang-Miao Chen, Wen-Jun Du, Jie Dai, Qian Zhang, Guang-Xin Si, Hong Yang, et al. Effects of Subclinical Hypothyroidism on Maternal and Perinatal Outcomes during Pregnancy: A Single-Center Cohort Study of a Chinese Population. PLOS ONE. 2014; 9(10): e109364. 19. Kalpesh K, Alpesh P, Harshid L. High prevalence of thyroid dysfunction among pregnant women in Ahmedabad City, Gujarat, India. Int J Adv Res. 2015; 3(8): 676-82. 20. Ojamaa K, Klemperer J D, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996; 6: 505– 512. 21. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002; 12: 421–425. 22. YunfeiCai, YongkuiRen, Jingpu Shi. Blood pressure levels in patients with subclinical thyroid dysfunction: a metaanalysis of cross-sectional data. The Japanese Society of Hypertension. Hypertension Research. 2011; 34: 1098– 1105. 23. Duan Y, Peng W, Wang X, Tang W, Liu X, Xu S, Mao X, Feng S, Feng Y, Qin Y, Xu K, Liu C. Community-based study of the association of subclinical thyroid dysfunction with blood pressure. Endocrine. 2009; 35: 136–142. 24. Walsh J P, Bremner A P, Bulsara M K, O'Leary P, Leedman P J, Feddema P, Michelangeli V. Subclinical thyroid dysfunction and blood pressure: a community-based study. ClinEndocrinol (Oxf). 2006; 65: 486–491. 25. Akter S N, Tarannum R, Kabir M S. Pregnancy in overt and subclinical hypothyroidism and its feto-maternal outcome. J Med Today. 2013; 25:02 26. Karthick N, Dillara K, Poornima K N, Subhasini A S. Dyslipidaemic changes in women with subclinical hypothyroidism. J ClinDiagn Res 2013; 7(10): 2122-5. 27. Knudsen N, Laurberg P, Lone B R, Bülow I, Perrild H, Ovesen L, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2013; 90(7): 4019-24. 28. Solanki A, Bansal S, Jindal S, Saxena V, Shukla U S. Relationship of serum thyroid stimulating hormone with body mass index in healthy adults. Indian J Endocrinol Metab. 2013; 17(Suppl1): S167-S9. 29. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian J Endocrinol Metab. 2016; 20(4): 554-7. 30. Leung A S, Millar L K, Koonings P P, Montoro M, Mestman J H. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol. 1993. 81:349–353. 31. Lipper E, Lee K, Gartner L M, Grellong B. Determinants of neurobehavioral outcome in low-birth-weights infants. Pediatrics. 1981; 67: 502–505. 32. Leitner Y, Fattal-Valevski A, Geva R, Eshel R, Toledano-Alhadef H, et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol. 2007; 22: 580– 587. 33. Fattal-Valevski A, Leitner Y, Kutai M, Tal-Posener E, Tomer A, et al. Neurodevelopmental outcome in children with intrauterine growth retardation: a 3- year follow-up. J Child Neurol. 1999; 14: 724–727. 34. Haddow J E, Palomaki G E, Allan W C, Williams J R, Knight G J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341: 549–555. 35. Idris I, Srinivasan R, Simm A. Maternal hypothyroidism in early and late gestation: effects on neonatal andobstetric outcome. Clin Endocrinol (Oxf). 2005; 63: 560–565. 36. Goel P, Radotra A, Devi K, Malhotra S, Aggarwal A, Huria A. Maternal and perinatal outcome in pregnancy with hypothyroidism. Indian J Med Sci. 2005; 59(3): 116–7. 37. Mannisto T, Vaarasmaki M, Pouta A, Hartikainen A L, Ruokonen A, Surcel H M, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective populationbased cohort study. J Clin Endocrinol Metab. 2009; 94(3): 772–9.